PAX3-FOXO1 Induces Up-Regulation of Noxa Sensitizing Alveolar Rhabdomyosarcoma Cells to Apoptosis

Alveolar rhabdomyosarcoma (ARMS) has a much poorer prognosis than the more common embryonal subtype. Most ARMS tumors characteristically possess a specific genomic translocation between the genes of PAX3/7 and FOXO1 (FKHR), which forms fusion proteins possessing the DNA binding domains of PAX3/7 and...

Full description

Bibliographic Details
Main Authors: Amy D. Marshall, Fabrizio Picchione, Ramon I. Klein Geltink, Gerard C. Grosveld
Format: Article
Language:English
Published: Elsevier 2013-07-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558613800681
_version_ 1819122576418406400
author Amy D. Marshall
Fabrizio Picchione
Ramon I. Klein Geltink
Gerard C. Grosveld
author_facet Amy D. Marshall
Fabrizio Picchione
Ramon I. Klein Geltink
Gerard C. Grosveld
author_sort Amy D. Marshall
collection DOAJ
description Alveolar rhabdomyosarcoma (ARMS) has a much poorer prognosis than the more common embryonal subtype. Most ARMS tumors characteristically possess a specific genomic translocation between the genes of PAX3/7 and FOXO1 (FKHR), which forms fusion proteins possessing the DNA binding domains of PAX3/7 and the more transcriptionally potent transactivation domain of FOXO1. We have shown that the proapoptotic BH3-only family member Noxa is upregulated by the PAX3-FOXO1 fusion transcription factor in a p53-independent manner. The increased expression of Noxa renders PAX3-FOXO1-expressing cells more susceptible to apoptosis induced by a ă-secretase inhibitor (GSI1, Z-LLNle-CHO), the proteasome inhibitor bortezomib, and BH3 mimetic ABT-737. Apoptosis in response to bortezomib can be overcome by shRNA knockdown of Noxa. In vivo treatment with bortezomib reduced the growth of tumors derived from a PAX3-FOXO1-expressing primary myoblast tumor model and RH41 xenografts. We therefore demonstrate that PAX3-FOXO1 up-regulation of Noxa represents an unanticipated aspect of ARMS tumor biology that creates a therapeutic window to allow induction of apoptosis in ARMS cells.
first_indexed 2024-12-22T06:54:39Z
format Article
id doaj.art-9338948efdc8457ca861b52738b52f93
institution Directory Open Access Journal
issn 1476-5586
1522-8002
language English
last_indexed 2024-12-22T06:54:39Z
publishDate 2013-07-01
publisher Elsevier
record_format Article
series Neoplasia: An International Journal for Oncology Research
spelling doaj.art-9338948efdc8457ca861b52738b52f932022-12-21T18:35:00ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022013-07-0115773874810.1593/neo.121888PAX3-FOXO1 Induces Up-Regulation of Noxa Sensitizing Alveolar Rhabdomyosarcoma Cells to ApoptosisAmy D. Marshall0Fabrizio Picchione1Ramon I. Klein Geltink2Gerard C. Grosveld3Department of Genetics, St Jude Children's Research Hospital, Memphis, TNDepartment of Genetics, St Jude Children's Research Hospital, Memphis, TNDepartment of Genetics, St Jude Children's Research Hospital, Memphis, TNDepartment of Genetics, St Jude Children's Research Hospital, Memphis, TNAlveolar rhabdomyosarcoma (ARMS) has a much poorer prognosis than the more common embryonal subtype. Most ARMS tumors characteristically possess a specific genomic translocation between the genes of PAX3/7 and FOXO1 (FKHR), which forms fusion proteins possessing the DNA binding domains of PAX3/7 and the more transcriptionally potent transactivation domain of FOXO1. We have shown that the proapoptotic BH3-only family member Noxa is upregulated by the PAX3-FOXO1 fusion transcription factor in a p53-independent manner. The increased expression of Noxa renders PAX3-FOXO1-expressing cells more susceptible to apoptosis induced by a ă-secretase inhibitor (GSI1, Z-LLNle-CHO), the proteasome inhibitor bortezomib, and BH3 mimetic ABT-737. Apoptosis in response to bortezomib can be overcome by shRNA knockdown of Noxa. In vivo treatment with bortezomib reduced the growth of tumors derived from a PAX3-FOXO1-expressing primary myoblast tumor model and RH41 xenografts. We therefore demonstrate that PAX3-FOXO1 up-regulation of Noxa represents an unanticipated aspect of ARMS tumor biology that creates a therapeutic window to allow induction of apoptosis in ARMS cells.http://www.sciencedirect.com/science/article/pii/S1476558613800681
spellingShingle Amy D. Marshall
Fabrizio Picchione
Ramon I. Klein Geltink
Gerard C. Grosveld
PAX3-FOXO1 Induces Up-Regulation of Noxa Sensitizing Alveolar Rhabdomyosarcoma Cells to Apoptosis
Neoplasia: An International Journal for Oncology Research
title PAX3-FOXO1 Induces Up-Regulation of Noxa Sensitizing Alveolar Rhabdomyosarcoma Cells to Apoptosis
title_full PAX3-FOXO1 Induces Up-Regulation of Noxa Sensitizing Alveolar Rhabdomyosarcoma Cells to Apoptosis
title_fullStr PAX3-FOXO1 Induces Up-Regulation of Noxa Sensitizing Alveolar Rhabdomyosarcoma Cells to Apoptosis
title_full_unstemmed PAX3-FOXO1 Induces Up-Regulation of Noxa Sensitizing Alveolar Rhabdomyosarcoma Cells to Apoptosis
title_short PAX3-FOXO1 Induces Up-Regulation of Noxa Sensitizing Alveolar Rhabdomyosarcoma Cells to Apoptosis
title_sort pax3 foxo1 induces up regulation of noxa sensitizing alveolar rhabdomyosarcoma cells to apoptosis
url http://www.sciencedirect.com/science/article/pii/S1476558613800681
work_keys_str_mv AT amydmarshall pax3foxo1inducesupregulationofnoxasensitizingalveolarrhabdomyosarcomacellstoapoptosis
AT fabriziopicchione pax3foxo1inducesupregulationofnoxasensitizingalveolarrhabdomyosarcomacellstoapoptosis
AT ramonikleingeltink pax3foxo1inducesupregulationofnoxasensitizingalveolarrhabdomyosarcomacellstoapoptosis
AT gerardcgrosveld pax3foxo1inducesupregulationofnoxasensitizingalveolarrhabdomyosarcomacellstoapoptosis